Lulizumab Biosimilar – Anti-CD28 mAb – Research Grade

Reference:
Product nameLulizumab Biosimilar - Anti-CD28 mAb - Research Grade
SourceCAS 1421830-13-8
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsLulizumab,BMS-931699,CD28 ,anti-CD28
ReferencePX-TA1354
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeV-kappa
ClonalityMonoclonal Antibody

Description of Lulizumab Biosimilar - Anti-CD28 mAb - Research Grade

General information on Anti-CD28 [Homo sapiens] (Lulizumab) Monoclonal Antibody

Lulizumab is a Monoclonal Antibody that targets CD28 and that has been investigated to treat Primary Sjögren’s Syndrome.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Lulizumab Biosimilar – Anti-CD28 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD28 Recombinant Protein
Antigen

CD28 Recombinant Protein

PX-P4080 310€
Human CD28 recombinant protein
Antigen

Human CD28 recombinant protein

PX-P4044 210€
Stable Isotope Labelled Lulizumab Biosimilar – Anti-CD28  mAb – Research Grade
SIL

Stable Isotope Labelled Lulizumab Biosimilar – Anti-CD28 mAb – Research Grade

PX-TA1354-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products